| scholarly article | Q13442814 |
| P50 | author | Ih Sheng Chen | Q26714512 |
| Jih-Hwa Guh | Q40601635 | ||
| Yunn-Fang Ho | Q58437432 | ||
| P2093 | author name string | Lih-Ching Hsu | |
| Jui-Ling Hsu | |||
| Hsun-Shuo Chang | |||
| Chia-Chun Yu | |||
| Yu-Jia Chang | |||
| Ping-Jung Wu | |||
| P2860 | cites work | Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex | Q24295120 |
| Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins | Q24519078 | ||
| Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis | Q28141949 | ||
| Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis | Q28186614 | ||
| Mechanisms of caspase activation | Q28187994 | ||
| Validating survivin as a cancer therapeutic target | Q28201382 | ||
| Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression | Q29617473 | ||
| IAP proteins: blocking the road to death's door | Q29619844 | ||
| Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway | Q30499567 | ||
| Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation | Q31034955 | ||
| Characterization of XIAP-deficient mice | Q33559119 | ||
| Targeting the translational machinery as a novel treatment strategy for hematologic malignancies | Q33747291 | ||
| Interaction of natural products with cell survival and signaling pathways in the biochemical elucidation of drug targets in cancer | Q33985206 | ||
| Survivin inhibition is critical for Bcl-2 inhibitor-induced apoptosis in hepatocellular carcinoma cells | Q33988315 | ||
| Recent advances in apoptosis, mitochondria and drug resistance in cancer cells | Q34174664 | ||
| Mammalian TOR: a homeostatic ATP sensor | Q34519173 | ||
| Survivin and IAP proteins in cell-death mechanisms | Q35414780 | ||
| The BCL-2 family reunion | Q35568029 | ||
| Recent advances in understanding the cell death pathways activated by anticancer therapy | Q36059491 | ||
| Executioner caspase-3 and caspase-7 are functionally distinct proteases | Q36861736 | ||
| IAPs: what's in a name? | Q37148694 | ||
| IAP-targeted therapies for cancer | Q37302745 | ||
| Mitochondria as targets for cancer chemotherapy | Q37356281 | ||
| Mitochondrial function and energy metabolism in cancer cells: past overview and future perspectives | Q37491422 | ||
| Targeting mitochondrial apoptosis by betulinic acid in human cancers | Q37516642 | ||
| VDAC, a multi-functional mitochondrial protein regulating cell life and death | Q37719811 | ||
| Drugs targeting Bcl-2 family members as an emerging strategy in cancer | Q37786022 | ||
| Emerging mitochondrial signaling mechanisms in physiology, aging processes, and as drug targets | Q37789845 | ||
| Functions and regulation of the 70kDa ribosomal S6 kinases. | Q37798912 | ||
| Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. | Q37826384 | ||
| Induction of cIAP-2 in Human Colon Cancer Cells through PKCδ/NF-κB | Q38349616 | ||
| 3-Thiomorpholin-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile (S1) based molecules as potent, dual inhibitors of B-cell lymphoma 2 (Bcl-2) and myeloid cell leukemia sequence 1 (Mcl-1): structure-based design and structure-activity relationship st | Q39607925 | ||
| Cytotoxic alkyl benzoquinones and alkyl phenols from Ardisia virens | Q39787039 | ||
| Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: a crucial role of AMPK and mTOR pathways. | Q39805239 | ||
| Genistein induces apoptosis in human hepatocellular carcinomas via interaction of endoplasmic reticulum stress and mitochondrial insult. | Q40190565 | ||
| Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak. | Q40263616 | ||
| ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells | Q40314359 | ||
| An IAP-IAP complex inhibits apoptosis | Q40541576 | ||
| Translational induction of the inhibitor of apoptosis protein HIAP2 during endoplasmic reticulum stress attenuates cell death and is mediated via an inducible internal ribosome entry site element. | Q40590393 | ||
| BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins. | Q40886681 | ||
| Endoplasmic reticulum stress-induced apoptosis in Leishmania through Ca2+-dependent and caspase-independent mechanism | Q41912110 | ||
| Involvement of ROS in chlorogenic acid-induced apoptosis of Bcr-Abl+ CML cells | Q42910611 | ||
| Design, synthesis, and interaction study of quinazoline-2(1H)-thione derivatives as novel potential Bcl-xL inhibitors | Q43092357 | ||
| The E3 ubiquitin ligase cIAP1 binds and ubiquitinates caspase-3 and -7 via unique mechanisms at distinct steps in their processing | Q43136832 | ||
| Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. | Q43509147 | ||
| Involvement of Akt in mitochondria-dependent apoptosis induced by a cdc25 phosphatase inhibitor naphthoquinone analog | Q44673360 | ||
| Costunolide induces apoptosis through nuclear calcium2+ overload and DNA damage response in human prostate cancer. | Q53260250 | ||
| P433 | issue | 2 | |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 133-145 | |
| P577 | publication date | 2012-06-05 | |
| P1433 | published in | The Prostate | Q7758608 |
| P1476 | title | Ardisianone, a natural benzoquinone, efficiently induces apoptosis in human hormone-refractory prostate cancers through mitochondrial damage stress and survivin downregulation | |
| P478 | volume | 73 |
| Q38775002 | A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma |
| Q38767151 | A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis |
| Q58800467 | Anti-Cancer Natural Products and Their Bioactive Compounds Inducing ER Stress-Mediated Apoptosis: A Review |
| Q39066878 | Antiproliferative and antimicrobial activities of alkylbenzoquinone derivatives from Ardisia kivuensis |
| Q39158194 | Cyclohexa-2,5-diene-1,4-dione-based antiproliferative agents: design, synthesis, and cytotoxic evaluation. |
| Q91504757 | Monocyclic Quinone Structure-Activity Patterns: Synthesis of Catalytic Inhibitors of Topoisomerase II with Potent Antiproliferative Activity |
| Q33841579 | Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs) |
| Q36625600 | ROS-mediated activation of AKT induces apoptosis via pVHL in prostate cancer cells |
| Q38852408 | Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway |
| Q38647185 | Role of Forkhead Box Class O proteins in cancer progression and metastasis |
| Q64248879 | The Role of the ER-Induced UPR Pathway and the Efficacy of Its Inhibitors and Inducers in the Inhibition of Tumor Progression |
Search more.